LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Summary

1Key Financial Results and Metrics

Net Revenue: $42.4 million, down 23.1% from $55.1 million in Q4 2025; also a 3.1% sequential decline from Q3 2026.

Revenue Breakdown:

Americas: $32.7 million (down 24.8%)

Asia-Pacific and Europe: $9.7 million (down 16.9%)

Gross Profit Margin: 78%, down from 79.9% year-over-year, impacted by product mix and increased expenses.

Operating Income: GAAP operating income of $1.7 million (down from $2.1 million); adjusted non-GAAP operating income of $1.8 million (down from $2.5 million).

Net Income: GAAP net income of $1.3 million ($0.10 per diluted share), compared to $2.0 million ($0.15 per diluted share) in Q4 2025; adjusted non-GAAP net income of $1.4 million ($0.11 per diluted share).

Cash Position: $14.9 million in cash, no debt; cash from operations was $10.2 million.

Share Repurchase: 85,700 shares repurchased in Q4 for approximately $459,000; total of 336,000 shares repurchased in FY 2026.

2Strategic Updates and Business Highlights

Leadership Transition: Terrence Moorehead has taken over as CEO, emphasizing the company's unique scientific foundation and untapped potential.

Strategic Focus:

Strengthening the LifeVantage brand and improving consumer communication.

Enhancing the consumer proposition and tools for the sales force.

Improving operational excellence and profitability.

Acquisition Impact: Sales from LoveBiome, acquired in October 2025, partially offset revenue declines.

Subscription Revenue: Remains strong, constituting over 75% of total revenue, with improved customer retention metrics.

3Forward Guidance and Outlook

No formal guidance provided for FY 2027 due to the recent leadership change.

Management anticipates potential stabilization and improvement in revenue trends by Q3 and Q4 of FY 2027, contingent on the implementation of new strategies.

4Bad News, Challenges, or Points of Concern

Declining Revenue: Significant year-over-year and sequential revenue declines, attributed to reduced orders and lower average order sizes.

Market Pressures: Economic conditions are exerting price pressure on consumers, affecting purchasing behavior.

Product-Specific Declines: Notable impact from the decline in sales of the higher-priced MindBody product.

Operational Challenges: Need for revitalization of brand positioning and consumer engagement strategies.

5Notable Q&A Insights

Monthly Trends: Sequential revenue decline noted, with expectations for improvement in the latter half of FY 2027.

International Expansion: Recognized as an opportunity, but focus will initially be on deepening penetration in existing markets rather than immediate expansion.

E-commerce Strategy: Plans to enhance digital capabilities and consumer access points, including website upgrades and improved sales tools.

Capital Expenditures: Expected to decrease slightly in FY 2027 as the company completes its Shopify integration, with future spending returning to historical levels. This summary encapsulates the key points from LifeVantage's Q4 2026 earnings call, highlighting both the challenges faced and the strategic initiatives being pursued under new leadership.